Tech Tonics: Matt Wilsey, Leading with Grace

February 8th, 2021 | | 37:21
Image for FaceBook

Share this post:
Facebook | Twitter | Google+ | LinkedIn | Pinterest | Reddit | Email
This post can be linked to directly with the following short URL:

The audio player code can be copied in different sizes:
144p, 240p, 360p, 480p, 540p, Other

The audio player code can be used without the image as follows:

This audio file can be linked to by copying the following URL:

Right/Ctrl-click to download the audio file.
Connected Social Media - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email
Tech Tonics - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email

Matt Wilsey grew up wanting to serve.  He spent his early career in government working for both blue and red administrations, but was eventually lured back to where he grew up–Silicon Valley—to join the tech scene, and helped start and lead several successful tech companies, including Zazzle and CardSpring (sold to Twitter).  Along the way Matt did a stint in the New York financial scene, working for leadership at KKR.   He considered a return to government, but real life, in the form of a child born with a rare disease, intervened.

Today, Matt Wilsey is CEO of Grace Science, a company that has a laser-like focus on curing a genetic disorder known as NGLY1 Deficiency, which affects about 75 people worldwide – it’s a pretty specific job which arose out a pretty specific experience – the desire to cure his own child, Grace.  Despite no training in science or biology and no experience in the pharma world, Matt is driving his company to help all people with NGLY1 find hope for a cure and find each other.  He is hell-bent on helping Grace back to health, on helping others fight this insidious disease, and to contribute to the general advancement of biotech discovery for common diseases along the way.

Matt has teamed up with patients, their families, a global array of academic researchers and even a Nobel laureate to achieve his goal; together they see light at the end of the tunnel.  Matt expects clinical trials of the drug they have collectively developed to begin within two years and to make a difference not just for future children with this disease, but also his own. We are so thrilled to have Matt on Tech Tonics today!

We are grateful to Manatt Health for sponsoring today’s episode of Tech Tonics.  Manatt Health integrates strategic business consulting, public policy acumen, legal excellence and deep analytics capabilities to better serve the complex needs of clients across America’s healthcare system. Together with it’s parent company, Manatt, Phelps & Phillips, the firm’s multidisciplinary team is dedicated to helping its clients across all industries grow and prosper.

Tags: , , , , , , , , , , ,
Posted in: Audio Podcast, Healthcare, Tech Tonics